Aju Mathew

Aju Mathew

University of Kentucky

H-index: 20

North America-United States

About Aju Mathew

Aju Mathew, With an exceptional h-index of 20 and a recent h-index of 17 (since 2020), a distinguished researcher at University of Kentucky, specializes in the field of Cancer research, Epidemiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Dying with dignity in India: What is new in 2023?

BRCAIndica: a Resource for ACMG/AMP classified BRCA1 and BRCA2 Variants

Local Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging Need

Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India

Legislation on cancer notification in India: current status

Income tax deduction as a tool to mitigate catastrophic health expenditure for cancer care falls short of its purpose in India

Triple Negative Breast Cancer in India: What Is the Real Incidence?

A burden shared: the financial, psychological, and health-related consequences borne by family members and caregivers of people with cancer in India

Aju Mathew Information

University

Position

Markey Cancer Center

Citations(all)

1677

Citations(since 2020)

1201

Cited By

922

hIndex(all)

20

hIndex(since 2020)

17

i10Index(all)

29

i10Index(since 2020)

24

Email

University Profile Page

Google Scholar

Aju Mathew Skills & Research Interests

Cancer research

Epidemiology

Top articles of Aju Mathew

Dying with dignity in India: What is new in 2023?

2023/5/10

Aju Mathew
Aju Mathew

H-Index: 13

BRCAIndica: a Resource for ACMG/AMP classified BRCA1 and BRCA2 Variants

2024/4/25

Ashish Joshi
Ashish Joshi

H-Index: 3

Aju Mathew
Aju Mathew

H-Index: 13

Local Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging Need

JCO Global Oncology

2024/3

Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India

JCO Global Oncology

2024/3

Legislation on cancer notification in India: current status

The Lancet Regional Health-Southeast Asia

2024/2/1

Aju Mathew
Aju Mathew

H-Index: 13

Income tax deduction as a tool to mitigate catastrophic health expenditure for cancer care falls short of its purpose in India

Indian Journal of Medical Sciences

2024/1

Aju Mathew
Aju Mathew

H-Index: 13

Triple Negative Breast Cancer in India: What Is the Real Incidence?

Indian Journal of Medical and Paediatric Oncology

2023/8

Aju Mathew
Aju Mathew

H-Index: 13

A burden shared: the financial, psychological, and health-related consequences borne by family members and caregivers of people with cancer in India

Supportive Care in Cancer

2023/7

Indian oncologists’ perception of the benefit of antiestrogen therapy in premenopausal women with hormone receptor positive non-metastatic breast cancer: An implementation …

2023/6/1

Aju Mathew
Aju Mathew

H-Index: 13

Incidence of hepatocellular cancer in India: Analysis of population based cancer registry data.

2023/6/1

Bin Huang
Bin Huang

H-Index: 10

Aju Mathew
Aju Mathew

H-Index: 13

Use of adjuvant bisphosphonate therapy in breast cancer by Indian oncologists: An implementation science study.

2023/6/1

Aju Mathew
Aju Mathew

H-Index: 13

Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India.

2023/6/1

Correlation between Magee score and recurrence score in Indian patients with breast cancer.

2023/6/1

Aju Mathew
Aju Mathew

H-Index: 13

A novel strategy to downstage breast cancer: impact of a phone helpline

ecancermedicalscience

2023

Sumit Datta
Sumit Datta

H-Index: 6

Aju Mathew
Aju Mathew

H-Index: 13

Corrigendum to “Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers”: Translational Oncology 2022 Nov; 25: 101511.

Translational Oncology

2023/1

Proportion of papillary thyroid microcarcinoma in Kerala, India, over a decade: a retrospective cohort study

ecancermedicalscience

2023

Aju Mathew
Aju Mathew

H-Index: 13

Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers

Translational Oncology

2022/11/1

Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis

2022/10/9

Aju Mathew
Aju Mathew

H-Index: 13

A comparative study of cancer drug approvals in india and high-income countries

Journal of Cancer Policy

2022/9/1

Value-based care in systemic therapy: the way forward

2022/8/16

Aju Mathew
Aju Mathew

H-Index: 13

See List of Professors in Aju Mathew University(University of Kentucky)